[Federal Register Volume 67, Number 176 (Wednesday, September 11, 2002)]
[Notices]
[Pages 57633-57634]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-23065]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Research and Development Cooperative Studies Evaluation 
Committee; Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under Public 
Law 92-463 (Federal Advisory Committee Act) that a meeting of the 
Research and Development, Cooperative Studies Evaluation Committee will 
be held at the Crystal City Marriott, 1999 Jefferson Davis Highway, 
Arlington, VA 22202, on October 3, 2002. The session is scheduled to 
begin at 8 a.m. and end at 5 p.m. The three new studies submitted for 
review are: Intensive vs Conventional Renal Support in Acute Renal 
Failure, Perioperative B--Adrenergic Receptor Blockage in Patients 
Undergoing Major Noncardiac Surgery, Anabolic Steroid Therapy on 
Pressure Ulcer Healing in Persons with SCI. In addition to the three 
new studies there will be one resubmission: Diiodothyroproprionic Acid, 
a Thyroid Analog to Treat Heart Failure and one progress review: 
Clinical Outcomes Utilizing Revascularization and Aggressive Drug 
Evaluation.
    The Committee advises the Chief Research and Development Officer 
through the Director of the Cooperative Studies Program on the 
relevance and feasibility of the studies, the adequacy of the 
protocols, and the scientific validity and propriety of technical 
details of proposed research.
    The meeting will be open to the public from 8 a.m. to 8:30 a.m. to 
discuss general status of the program. Those who plan to attend should 
contact Ms. Denise Shorter, Coordinator, Department of Veterans 
Affairs, Washington, DC at (202) 565-7016.
    The meeting will be closed from 8:30 a.m. to 5 p.m. This portion of 
the meeting involves consideration of specific proposals in accordance 
with provisions set forth in section 10(d) of Public Law 92-463, as 
amended by sections 5(c) of Public Law 94-409, and 5 U.S.C. 552b(c)(6). 
During the closed session of the meeting, discussions and 
recommendations will address qualifications of study personnel, 
critiques of research proposals, and similar documents, and the medical 
records of patients who are study subjects, the disclosure of which 
would constitute a clearly unwarranted invasion of personnel privacy.

    By Direction of the Secretary.


[[Page 57634]]


    Dated: August 30, 2002.
Nora E. Egan,
Committee Management Officer.
[FR Doc. 02-23065 Filed 9-10-02; 8:45 am]
BILLING CODE 8320-01-M